文献速递妇科生殖医学

激素避孕使用时长、近期使用及类型与抗苗勒管激素水平的关系

Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels.
PubMed 文献 · Fertil Steril · 2021-03-19

本研究基于1,643名23-35岁非洲裔美国女性的横断面数据,分析激素避孕使用与AMH水平的关系。结果显示,当前使用者AMH平均水平较非使用者低25.2%(95%CI:-35.3%,-13.6%),而既往使用者与非使用者差异无统计学意义(-4.4%,95%CI:-16.3%,9.0%),提示激素避孕对AMH的抑制效应可逆。

要点

  • 当前激素避孕使用者AMH水平显著低于非使用者,降幅25.2%。
  • 既往使用者AMH与非使用者无显著差异,抑制效应可逆。
  • 复合口服避孕药、阴道环、长效甲羟孕酮均与AMH降低相关。

核心结论

  • 当前使用多数类型激素避孕药的女性AMH水平显著低于非使用者,但该抑制效应在停用后可逆。

研究设计与样本

  • 横断面研究,基于环境、生活方式与子宫肌瘤研究(5年纵向研究)的基线数据,纳入1,643名23-35岁非洲裔美国女性,采血时间为2010-2012年。

主要发现

  • 当前激素避孕使用者平均AMH水平较非使用者低25.2%(95%CI:-35.3%,-13.6%)。
  • 既往使用者与非使用者AMH水平差异较小(-4.4%,95%CI:-16.3%,9.0%)。
  • 既往使用者的累积使用时长及非当前使用者的末次使用时间与AMH水平无明显关联。
  • 当前使用复合口服避孕药者AMH低24.0%(95%CI:-36.6%,-8.9%),使用阴道环者低64.8%(95%CI:-75.4%,-49.6%),使用长效甲羟孕酮者低26.7%(95%CI:-41.0%,-8.9%)。

临床怎么用

  • 解读AMH水平时应考虑当前激素避孕使用状态,避免误判卵巢储备。
  • 对于近期停用激素避孕者,AMH的抑制效应可能已可逆,但仍需结合临床背景评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether the duration, recency, or type of hormonal contraceptive used is associated with antimüllerian hormone (AMH) levels, given that the existing literature regarding the association between hormonal contraceptive use and AMH levels is inconsistent. DESIGN: Cross-sectional study. SETTING: Baseline data from the Study of the Environment, Lifestyle and Fibroids Study, a 5-year longitudinal study of African American women. PATIENT(S): The patients were 1,643 African American women aged 23-35 years at the time of blood drawing (2010-2012). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum AMH level was measured by an ultrasensitive enzyme-linked immunosorbent assay. Linear regression models were used to estimate percent differences in mean AMH levels and 95% confidence intervals (CIs) according to use of hormonal contraceptives, with adjustment for potential confounders. RESULT(S): In multivariable-adjusted analyses, current users of hormonal contraceptives had 25.2% lower mean AMH levels than non-users of hormonal contraceptives (95% CI: -35.3%, -13.6%). There was little difference in AMH levels between former users and non-users of hormonal contraceptives (-4.4%; 95% CI: -16.3%, 9.0%). AMH levels were not appreciably associated with cumulative duration of use among former users or time since last use among non-current users. Current users of combined oral contraceptives (-24.0%; 95% CI: -36.6%, -8.9%), vaginal ring (-64.8%; 95% CI: -75.4%, -49.6%), and depot medroxyprogesterone acetate (-26.7%; 95% CI: -41.0%, -8.9%) had lower mean AMH levels than non-users. CONCLUSION(S): The present data suggest that AMH levels are significantly lower among current users of most forms of hormonal contraceptives, but that the suppressive effect of hormonal contraceptives on AMH levels is reversible.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Bernardi LA, Weiss MS, Waldo A, et al. Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels. Fertil Steril. 2021. PMID: 33752880. doi:10.1016/j.fertnstert.2021.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。